The shares of Aerovate Therapeutics, Inc. (NASDAQ: AVTE) are on a notable uptick after the announcement of a merger agreement between the company and Jade Biosciences. On
Aerovate Therapeutics, Inc. (AVTE) saw an increase of 5.17% in the aftermarket. However, the last trading session concluded at $14.13 with a decline of 18.65%.
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.